| Name | Title | Contact Details |
|---|
OnlineMedsource is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedRep Surgical Inc is a Minnesota, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
At PopHealthCare, we believe healthcare should be personal. For us, that means bringing care to those who need it most, where they will be able to achieve their health goals best–at home or wherever they reside. Using in-home assessments and cutting-edge analytics, we identify high-risk patients and partner with health plans to keep them out of the hospital with our care team of compassionate, smart, deeply committed healthcare providers available 24/7. This commitment and integrity expands to all areas of our business. With over 22 clients in 17 states, PopHealthCare offers a fully integrated approach to care delivery, risk adjustment and quality enhancements, serving the highest risk populations with unwavering dedication. Our risk adjustment solutions include not only risk adjustment, but also chart retrievals and analytics and reporting, to help you effectively manage your risk adjustment program. Our goal is to facilitate risk score accuracy and help clients plan for the future with more precision, leveraging our unique combination of technology, in-depth industry expertise, and concierge-level service. Emcara Health, PopHealthCare`s value-based national medical group that does house calls for vulnerable populations, delivers personalized, attentive care either as the Primary Care Provider (PCP) or in collaboration with a patient`s community-based PCP. PopHealthcare`s success in spearheading the transformation of in-home care enables Emcara Health to deliver industry-leading outcomes in patient experience, care quality, cost of care, health equity, and employee satisfaction. As part of the GuideWell family of companies, we are working hard every day to improve the delivery of care through new innovative models that provide superior health outcomes for patients and our partners.
We created the first FDA-cleared app-enabled thermometer because, from our work in the health systems within the U.S. and across impoverished nations throughout the world, we`ve learned that an elevated temperature is often the first sign of sickness. By building intelligence into a once basic thermometer and turning it into a connected device, we`re able to keep an eye on illnesses from beginning to end. We can more quickly alert users when fever and symptoms warrant closer monitoring or a visit to the doctor. Our network of connected thermometers can even offer helpful insights such as common illnesses that may be circulating in a local area or within a user`s school. Kinsa is ready to help whole communities better track, treat, and stop the spread of illness. But we know we`ll only do it if our products delight users from their first touch. It’s with this in mind that we developed the Kinsa Smart Thermometer.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.